Are we shifting attrition downstream in the HIV cascade?

As countries begin removing CD4 threshold barriers to antiretroviral therapy (ART) initiation (ie, treat all)1 for those with HIV, questions remain as to how countries will implement this strategy. Because numerous reviews have shown that retention in all stages of the HIV care cascade is less than optimal,2–5 one important question is whether changing ART eligibility criteria will, or should be, accompanied by interventions to improve retention within the HIV care cascade. In The Lancet HIV, Jack Olney and colleagues6 assessed this topic with intriguing results.